Home » Topics » BioWorld Science, Respiratory

BioWorld Science, Respiratory
RSS

RPR redirects development of PDE IV inhibitor

Nov. 21, 1997

New NK3/NK4 antagonist in the pipeline at SKB

Nov. 20, 1997

Extensive preclinical results described for new NK2 antagonist

Nov. 20, 1997

Beclometasone CFC-free MDI for chronic bronchial asthma approved

Nov. 20, 1997

FDA clears first inhaled corticosteroid for young children with asthma

Nov. 18, 1997

FDA clears new Tilade formulation

Nov. 18, 1997

Pharmacokinetic profile of ciclosporin derivative IMM-125

Nov. 18, 1997

FACET study demonstrates improved asthma control with Pulmicort and Oxis

Nov. 17, 1997

Novartis claims new antiasthmatic agents

Nov. 17, 1997

Pfizer describes new PDE IV inhibitor for asthma

Nov. 14, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
Deerfield-backed Boulevard, Metis pen $1.6B trispecific TCE deal
BioWorld
A U.S. biotechnology company founded by Deerfield Management Company L.P. licensed exclusive rights to Metis Techbio Co. Ltd.’s preclinical trispecific T-cell...